Acquisition of Biochemical Reagent Solution

This tender concerns the acquisition of biochemical reagent solutions. The contracting authority is the State Secretariat of Health, with the specific unit being the Guilherme Alvaro Hospital in Santos, São Paulo. The procurement process is being conducted through an electronic bidding modality, specifically a "Pregão" (a type of public auction for common goods and services), operating under an open-closed bidding mode. This modality is mandated by Law 14.133/2021, Article 28, item I, for the procurement of common goods and services. The procurement process number is 02400180760202571, and the purchase number is 90072. Interested parties can access clarifications and challenges related to this tender notice via the provided link: https://cnetmobile.estaleiro.serpro.gov.br/comprasnet-web/public/landing?destino=quadro-informativo&compra=09014105900722026. The bidding process is scheduled to open for proposal submission on February 26, 2026, at 08:00, with the proposal submission deadline set for March 17, 2026, at 10:00. This acquisition is crucial for the operational needs of the Guilherme Alvaro Hospital, ensuring the availability of necessary biochemical reagents for laboratory diagnostics and patient care within the public health system in Santos, São Paulo.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Laboratory and Pharmaceuticals. Located in Brazil, Latin America, this opportunity is open to firms and consortiums.

Published through Brazil PNCP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.